Cellular sources and targets of IFN-γ-mediated protection against viral demyelination and neurological deficits

Paul D. Murray, Dorian B. McGavern, Larry R. Pease, Moses Rodriguez

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

IFN-γ is an anti-viral and immunomodulatory cytokine critical for resistance to multiple pathogens. Using mice with targeted disruption of the gene for IFN-γ, we previously demonstrated that this cytokine is critical for resistance to viral persistence and demyelination in the Theiler's virus model of multiple sclerosis. During viral infections, IFN-γ is produced by natural killer (NK) cells, CD4+ and CD8+ T cells; however, the proportions of lymphocyte subsets responding to virus infection influences the contributions to IFN-γ-mediated protection. To determine the lymphocyte subsets that produce IFN-γ to maintain resistance, we used adoptive transfer strategies to generate mice with lymphocyte-specific deficiencies in IFN-γ-production. We demonstrate that IFN-γ production by both CD4+ and CD8+ T cell subsets is critical for resistance to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination and neurological disease, and that CD4+ T cells make a greater contribution to IFN-γ-mediated protection. To determine the cellular targets of IFN-γ-mediated responses, we used adoptive transfer studies and bone marrow chimerism to generate mice in which either hematopoietic or somatic cells lacked the ability to express IFN-γ receptor. We demonstrate that IFN-γ receptor must be present on central nervous system glia, but not bone marrow-derived lymphocytes, in order to maintain resistance to TMEV-induced demyelination.

Original languageEnglish (US)
Pages (from-to)606-615
Number of pages10
JournalEuropean Journal of Immunology
Volume32
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Theilovirus
Demyelinating Diseases
Adoptive Transfer
Lymphocyte Subsets
Virus Diseases
Bone Marrow
Lymphocytes
Cytokines
T-Lymphocytes
Chimerism
T-Lymphocyte Subsets
Neuroglia
Natural Killer Cells
Multiple Sclerosis
Central Nervous System
Genes

Keywords

  • Glia
  • Multiple sclerosis
  • Neuroimmunology
  • Oligodendrocyte
  • T cell

ASJC Scopus subject areas

  • Immunology

Cite this

Cellular sources and targets of IFN-γ-mediated protection against viral demyelination and neurological deficits. / Murray, Paul D.; McGavern, Dorian B.; Pease, Larry R.; Rodriguez, Moses.

In: European Journal of Immunology, Vol. 32, No. 3, 2002, p. 606-615.

Research output: Contribution to journalArticle

Murray, Paul D. ; McGavern, Dorian B. ; Pease, Larry R. ; Rodriguez, Moses. / Cellular sources and targets of IFN-γ-mediated protection against viral demyelination and neurological deficits. In: European Journal of Immunology. 2002 ; Vol. 32, No. 3. pp. 606-615.
@article{d0bbd460fbfc46ed9fb1940f0d95d9b1,
title = "Cellular sources and targets of IFN-γ-mediated protection against viral demyelination and neurological deficits",
abstract = "IFN-γ is an anti-viral and immunomodulatory cytokine critical for resistance to multiple pathogens. Using mice with targeted disruption of the gene for IFN-γ, we previously demonstrated that this cytokine is critical for resistance to viral persistence and demyelination in the Theiler's virus model of multiple sclerosis. During viral infections, IFN-γ is produced by natural killer (NK) cells, CD4+ and CD8+ T cells; however, the proportions of lymphocyte subsets responding to virus infection influences the contributions to IFN-γ-mediated protection. To determine the lymphocyte subsets that produce IFN-γ to maintain resistance, we used adoptive transfer strategies to generate mice with lymphocyte-specific deficiencies in IFN-γ-production. We demonstrate that IFN-γ production by both CD4+ and CD8+ T cell subsets is critical for resistance to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination and neurological disease, and that CD4+ T cells make a greater contribution to IFN-γ-mediated protection. To determine the cellular targets of IFN-γ-mediated responses, we used adoptive transfer studies and bone marrow chimerism to generate mice in which either hematopoietic or somatic cells lacked the ability to express IFN-γ receptor. We demonstrate that IFN-γ receptor must be present on central nervous system glia, but not bone marrow-derived lymphocytes, in order to maintain resistance to TMEV-induced demyelination.",
keywords = "Glia, Multiple sclerosis, Neuroimmunology, Oligodendrocyte, T cell",
author = "Murray, {Paul D.} and McGavern, {Dorian B.} and Pease, {Larry R.} and Moses Rodriguez",
year = "2002",
doi = "10.1002/1521-4141(200203)32:3<606::AID-IMMU606>3.0.CO;2-D",
language = "English (US)",
volume = "32",
pages = "606--615",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "3",

}

TY - JOUR

T1 - Cellular sources and targets of IFN-γ-mediated protection against viral demyelination and neurological deficits

AU - Murray, Paul D.

AU - McGavern, Dorian B.

AU - Pease, Larry R.

AU - Rodriguez, Moses

PY - 2002

Y1 - 2002

N2 - IFN-γ is an anti-viral and immunomodulatory cytokine critical for resistance to multiple pathogens. Using mice with targeted disruption of the gene for IFN-γ, we previously demonstrated that this cytokine is critical for resistance to viral persistence and demyelination in the Theiler's virus model of multiple sclerosis. During viral infections, IFN-γ is produced by natural killer (NK) cells, CD4+ and CD8+ T cells; however, the proportions of lymphocyte subsets responding to virus infection influences the contributions to IFN-γ-mediated protection. To determine the lymphocyte subsets that produce IFN-γ to maintain resistance, we used adoptive transfer strategies to generate mice with lymphocyte-specific deficiencies in IFN-γ-production. We demonstrate that IFN-γ production by both CD4+ and CD8+ T cell subsets is critical for resistance to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination and neurological disease, and that CD4+ T cells make a greater contribution to IFN-γ-mediated protection. To determine the cellular targets of IFN-γ-mediated responses, we used adoptive transfer studies and bone marrow chimerism to generate mice in which either hematopoietic or somatic cells lacked the ability to express IFN-γ receptor. We demonstrate that IFN-γ receptor must be present on central nervous system glia, but not bone marrow-derived lymphocytes, in order to maintain resistance to TMEV-induced demyelination.

AB - IFN-γ is an anti-viral and immunomodulatory cytokine critical for resistance to multiple pathogens. Using mice with targeted disruption of the gene for IFN-γ, we previously demonstrated that this cytokine is critical for resistance to viral persistence and demyelination in the Theiler's virus model of multiple sclerosis. During viral infections, IFN-γ is produced by natural killer (NK) cells, CD4+ and CD8+ T cells; however, the proportions of lymphocyte subsets responding to virus infection influences the contributions to IFN-γ-mediated protection. To determine the lymphocyte subsets that produce IFN-γ to maintain resistance, we used adoptive transfer strategies to generate mice with lymphocyte-specific deficiencies in IFN-γ-production. We demonstrate that IFN-γ production by both CD4+ and CD8+ T cell subsets is critical for resistance to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination and neurological disease, and that CD4+ T cells make a greater contribution to IFN-γ-mediated protection. To determine the cellular targets of IFN-γ-mediated responses, we used adoptive transfer studies and bone marrow chimerism to generate mice in which either hematopoietic or somatic cells lacked the ability to express IFN-γ receptor. We demonstrate that IFN-γ receptor must be present on central nervous system glia, but not bone marrow-derived lymphocytes, in order to maintain resistance to TMEV-induced demyelination.

KW - Glia

KW - Multiple sclerosis

KW - Neuroimmunology

KW - Oligodendrocyte

KW - T cell

UR - http://www.scopus.com/inward/record.url?scp=0036210434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036210434&partnerID=8YFLogxK

U2 - 10.1002/1521-4141(200203)32:3<606::AID-IMMU606>3.0.CO;2-D

DO - 10.1002/1521-4141(200203)32:3<606::AID-IMMU606>3.0.CO;2-D

M3 - Article

C2 - 11857334

AN - SCOPUS:0036210434

VL - 32

SP - 606

EP - 615

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 3

ER -